Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:CBIO?
Track your performance easily
GB:CBIO Price & Analysis
CBIO ETF Chart & Stats
Day’s Range― - ―
52-Week Range$19.32 - $29.72
Previous Close$20.48
VolumeN/A
Average Volume (3M)490.00
AUM1.03M
NAV20.51
Expense Ratio0.68%
Holdings Count32
Beta1.08
Inception DateJan 18, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume490
AlphaN/A
Global X China Biotech UCITS ETF AccumUSD (CBIO) Fund Flow Chart
Global X China Biotech UCITS ETF AccumUSD (CBIO) 1 year Net Flows: -$499K
CBIO ETF News
PremiumCompany Announcements
Akeso, Inc. Appoints New CFO, Dr. Bing Wang
PremiumCompany Announcements
Hansoh Pharma’s Ameile Gains New Drug Acceptance
PremiumCompany Announcements
Sino Biopharmaceutical Excels in ESG Performance
PremiumCompany Announcements
Sino Biopharmaceutical’s Breast Cancer Drug AdvancesCBIO ETF FAQ
What was GB:CBIO’s price range in the past 12 months?
GB:CBIO lowest ETF price was $19.32 and its highest was $29.71 in the past 12 months.
What is the AUM of GB:CBIO?
As of Jul 19, 2024 The AUM of GB:CBIO is 1.03M.
Is GB:CBIO overvalued?
According to Wall Street analysts GB:CBIO’s price is currently Undervalued.
Does GB:CBIO pay dividends?
GB:CBIO does not currently pay dividends.
How many shares outstanding does GB:CBIO have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:CBIO?
Currently, no hedge funds are holding shares in GB:CBIO
Top 10 Holdings
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
9.10%
WuXi AppTec Co., Ltd. Class A
9.07%
Innovent Biologics
8.88%
Wuxi Biologics (Cayman)
7.14%
Shanghai RAAS Blood Products Co., Ltd. Class A
6.48%
Sino Biopharmaceutical
4.78%
Beijing Tiantan Biological Products Corporation Limited Class A
4.68%
Akeso, Inc.
3.76%
Shenyang Xingqi Pharmaceutical Co., Ltd. Class A
3.40%
Hansoh Pharmaceutical Group Company Limited
3.35%
Total60.63%
ETF Description
Global X China Biotech UCITS ETF AccumUSD
The investment objective of the Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China Biotech v2 USD Index NTR